Election 2014
SENSEX NIFTY
You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > UTI Mutual Fund > UTI Pharma & Healthcare Fund (G)

UTI Pharma & Healthcare Fund (G) SET SMS ALERT

60.696
0.26 (0.43%)
NAV as on Apr-16-2014
ranking by CRISIL

Not Ranked

This scheme is not ranked by CRISIL since it does not fulfill certain eligibility criteria of CRISIL

View Top ranked funds in other categories

Benchmark Index:
 
View Historic Graph From     To     

Returns (NAV as on Apr-16-2014)

Period Returns (%) Rank #
1 mth 1.1 4
3 mth 2.1 6
6 mth 10.7 6
1 year 26.4 6
2 year 20.8 3
3 year 15.4 3
5 year 26.1 3

# Moneycontrol Rank within 6 Sector - Pharma & Healthcare Schemes.

Absolute Returns (in %)

Year Qtr 1 Qtr 2 Qtr 3 Qtr 4 Annual
2014 0.9 - - - -
2013 -4.1 10.0 5.5 8.3 23.0
2012 6.9 2.3 8.0 4.9 25.0
2011 -7.8 6.1 -7.2 -0.7 -10.0
2010 11.8 8.9 1.4 9.9 37.4
2009 -1.3 18.2 25.1 -0.2 65.7

View where it stands within its peers

* Returns over 1 year are Annualised

Performance

Fund returns v/s Category average (Sector - Pharma & Healthcare)

* Returns over 1 year are Annualised
  1 mth (%) 3 mth (%) 6 mth (%) 1 yr (%) 2 yr (%) 3 yr (%) 5yr (%)
Fund Returns 1.1 2.1 10.7 26.4 20.8 15.4 26.1
Category avg 0.8 3.3 13.7 28.4 11.7 9.0 15.4
Difference of Fund returns and Category returns 0.3 -1.2 -3.0 -2.0 9.1 6.4 10.7
Best of category 1.3 4.2 18.6 29.7 27.6 22.0 33.7
Worst of category -0.1 2.1 10.7 26.4 20.8 15.4 26.1
Benchmark returns # 1.4 0.8 4.4 25.3 24.1 20.0 --
Difference of Fund returns and Benchmark returns -0.3 1.3 6.3 1.1 -3.3 -4.6 26.1
# Benchmark Index: CNX Pharma

Investment Info

Investment Objective

Investment will be made in stocks of companies engaged in manufacturing of Pharmaceuticals bulk drugs, formulations & OTC drugs, medical equipment and accessories, personal healthcare products and also companies owning/managing hospitals etc.

Scheme details

Fund Type Open-Ended
Investment Plan Growth
Launch date Jun 26, 1999
Benchmark CNX Pharma
Asset Size (Rs cr) 128.70 (Dec-31-2013)
Minimum Investment Rs.5000
Last Dividend N.A. View Dividend History
Bonus N.A.
Fund Manager Lalit Nambiar
View performance of schemes managed by the Fund Manager
Notes N.A

Load Details

Entry Load N.A
Exit Load 1.00%
Load Comments Exit Load 1% if redeemed within 1 Year from the date of allotment.

Contact Details

Regd. Office UTI Tower, Gn Block, Bandra-Kurla Complex, Bandra (E), Mumbai, 400051
Tel. No. 66786666
Fax No. 26524921
Email uti@giasbm01.vsnl.net.in
Website http://www.utimf.com

Peer Comparison

Sector - Pharma & Healthcare Crisil Rank Assets (Rs.cr)
3mth (%) 6mth (%) 1yr (%) 3yr (%) 5yr (%)
Reliance Pharma Fund (G) Not Ranked
703.28 4.0 18.1 28.6 16.6 33.7
SBI Pharma Fund (G) Not Ranked
130.15 3.6 11.6 28.8 22.0 32.8
SBI Pharma Fund - Direct (G) Not Ranked
16.29 3.8 12.0 29.7 -- --
UTI Pharma & Health (G) Not Ranked
128.70 2.1 10.7 26.4 15.4 26.1
UTI Pharma & Health - Direct (G) Not Ranked
2.62 2.3 11.1 27.3 -- --
* Returns over 1 year are Annualised More »

Portfolio

Top Holdings (Feb 28, 14)

Equity Sector Value
(Rs cr)
Asset %
Sun Pharma Pharmaceuticals 35.57 22.80
Dr Reddys Labs Pharmaceuticals 25.70 16.48
Lupin Pharmaceuticals 14.61 9.37
Cipla Pharmaceuticals 13.50 8.65
GlaxoSmithKline Pharmaceuticals 9.96 6.38
Divis Labs Pharmaceuticals 8.19 5.25
Biocon Pharmaceuticals 5.89 3.78
Cadila Health Pharmaceuticals 4.89 3.13
Glenmark Pharmaceuticals 4.04 2.59
Aurobindo Pharm Pharmaceuticals 3.34 2.14

Full Portfolio

Sector Allocation (Feb 28, 14)

Sector %

1-Year

HighLow

Pharmaceuticals 93.30 95.42 90.30

View All Sectors

Asset Allocation (%)(Feb 28, 14)

Equity 93.30
Others 0.00
Debt 0.07
Mutual Funds N.A
Money Market 0.00
Cash / Call 6.65

View All

Concentration

Holdings (%)
Top 5 63.68
Top 10 80.57
Sector (%)
Top 3 93.30

News & Videos

Messages & Community

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.